1.PERJETA® is a first-line treatment for HER2positive metastatic breast cancer. • PERJETA is an FDA-approved treatment for HER2-positive metastatic breast cancer. It is…
Journal of Cancer 2013, Vol. 4 http://www.jcancer.org 117 JJoouurrnnaall ooff CCaanncceerr 2013; 4(2): 117-132. doi: 10.7150/jca.4925 Review Treating Breast Cancer in the…